Understanding Carbapenemase Gene Dynamics in CREC: Insights from Guangdong Hospitals (2022–2024)

Study Background and Research Question

The rapid emergence of carbapenem-resistant Enterobacteriaceae (CRE) represents a mounting public health challenge, with Enterobacter cloacae (CREC) ranking among the most prevalent CRE pathogens in China. The COVID-19 pandemic has further complicated resistance patterns due to increased antibiotic usage and disruptions to clinical workflows. While the role of carbapenemase-encoding genes (CEGs) in mediating resistance is established, the specific genetic characteristics and transmission dynamics of these genes in CREC populations—especially under pandemic pressures—remain insufficiently characterized. The reference study by Chen et al. (BMC Microbiology, 2025) addresses this gap by analyzing 54 CREC isolates from eight Guangdong teaching hospitals collected between December 2022 and June 2024, with a focus on the molecular epidemiology and horizontal gene transfer of CEGs.

Key Innovation from the Reference Study

The innovation of this study lies in its comprehensive mapping of CEGs—especially the blaNDM-1 gene—across both chromosomal and plasmid locations in clinical CREC isolates. By integrating molecular typing, conjugation, and epidemiological analysis, the researchers provide high-resolution evidence of how CEGs disseminate within and between hospital settings during a period of heightened antimicrobial use. The study not only clarifies the relative contributions of plasmids and chromosomes to resistance but also quantifies the transfer rates of key resistance genes, thereby informing future surveillance and containment strategies.

Methods and Experimental Design Insights

Chen et al. employed a multi-pronged approach to dissect the genetic landscape and transferability of carbapenem resistance in CREC:

• Sample Collection: 54 CREC isolates were prospectively collected from eight geographically distributed teaching hospitals in Guangdong Province over 18 months.
• Genetic Characterization: The variable temperature Sodium Dodecyl Sulfate (SDS) plasmid elimination method and PCR were used to detect and localize CEGs (including blaNDM-1, blaIMP, and blaKPC-2) on plasmids and/or chromosomes.
• Antimicrobial Susceptibility Testing: The broth microdilution method profiled resistance to multiple antibiotics, enabling comparison between CEG-positive and -negative cohorts.
• Conjugation Experiments: Plasmid transferability was assessed via conjugation assays and subsequent PCR validation of recipient strains.
• Molecular Typing: ERIC-PCR and NTSYS software were employed to cluster isolates into genotypes, supporting epidemiological tracing of transmission events.

These methodologies enabled the study to link genetic findings with clinical and demographic data, including age, gender, specimen type, and hospital department, to contextualize resistance spread.

Core Findings and Why They Matter

The study's findings have broad implications for both microbiology research and hospital infection control:

• High Prevalence of CEGs: 85.19% of CREC isolates harbored at least one CEG, with blaNDM-1 being predominant. Notably, 33.33% carried blaNDM-1 on both plasmids and chromosomes, while 46.30% had it exclusively on plasmids (Chen et al.).
• Multidrug Resistance: CEG-positive isolates demonstrated significantly greater resistance to major antibiotics, including imipenem and cefepime, compared to CEG-negative strains (P < 0.05).
• Efficient Horizontal Gene Transfer: Conjugation experiments showed a 95.65% success rate for plasmid-mediated transfer of CEGs, with blaNDM-1 and blaIMP highly transmissible, underscoring the risk of rapid resistance dissemination.
• Mobile Genetic Elements: Six types of mobile genetic elements were identified, with ISEcp1 present in 87.04% of isolates. The co-occurrence of multiple elements in single strains (40.74%) suggests a dynamic landscape for gene mobilization.
• Molecular Epidemiology: ERIC-PCR categorized isolates into 17 genotypes, with types E and G predominating across multiple hospitals and departments, suggesting clonal expansion and cross-departmental transmission.
• Clinical Correlates: Higher detection rates were observed in male and elderly patients, within respiratory units, and in sputum samples, directing attention to high-risk populations for surveillance.

Collectively, these results highlight the centrality of plasmid-mediated blaNDM-1 in the propagation of carbapenem resistance in CREC, and the multidimensional nature of its spread during the COVID-19 era.

Comparison with Existing Internal Articles

Several internal resources provide complementary perspectives on both the technical and practical aspects of resistance research involving carbapenems:

• The article "Ertapenem Sodium Salt: Workflow Enhancements for Resistance Research" emphasizes the importance of standardized reagents, such as high-purity Ertapenem sodium salt, for reproducible susceptibility profiling in both Gram-positive and Gram-negative bacteria. While Chen et al. focus on genetic and epidemiological analysis, this internal resource bridges to practical protocol design, highlighting the need for reliable antibiotics in experimental setups.
• "Ertapenem Sodium Salt: Molecular Pharmacokinetics and Resistance Dynamics" details the pharmacokinetics of ertapenem, including distribution and renal elimination, which is crucial for modeling in vitro and in vivo resistance selection. This complements the reference study by providing context for choosing appropriate dosing and monitoring parameters during resistance assays.
• "Transmission Dynamics of Carbapenemase Genes in CREC in Guangdong" offers a concise summary of the same study, reinforcing the central role of plasmid-borne blaNDM-1 and the necessity of integrating molecular epidemiology with experimental design in antibiotic resistance research.

In contrast to workflow- or compound-focused articles, the reference study delivers an in-depth, field-based genetic perspective, underscoring the value of integrating molecular tools and clinical surveillance.

Limitations and Transferability

Despite its strengths, the study is subject to several limitations:

• Geographical Scope: The analysis is limited to eight teaching hospitals within one province, which may not capture regional or national variation in CREC genotypes or resistance mechanisms.
• Temporal Window: Sampling occurred during the COVID-19 pandemic; resistance dynamics may shift as clinical pressures change.
• Focus on Select Genes: Although the study covers the most clinically relevant CEGs, other resistance determinants may be present but uncharacterized.
• Transferability: While the findings provide a robust template for molecular epidemiology elsewhere, local strain diversity and mobile element composition should be considered when extrapolating results to different settings or species.

Protocol Parameters

• Isolate screening: Use PCR or whole-genome sequencing to detect CEGs (e.g., blaNDM-1, blaIMP, blaKPC-2) in Enterobacteriaceae clinical isolates.
• Plasmid elimination: Employ variable temperature SDS treatment prior to conjugation studies to localize resistance determinants.
• Conjugation assays: Pair donor CREC isolates with suitable recipient strains, monitor transfer by PCR after co-incubation, and confirm multidrug resistance phenotypes by broth microdilution.
• Molecular typing: Apply ERIC-PCR and standardized clustering analysis (e.g., NTSYS) for epidemiological tracking of genotypes.
• Antibiotic susceptibility profiling: Utilize the broth microdilution method with accurate MIC reference standards, such as Ertapenem sodium salt, for consistent results.

Research Support Resources

To support similar experiments, researchers may use Ertapenem (sodium salt) (SKU C3451) as a reference antibacterial agent in susceptibility and resistance transmission assays. This compound, offered by APExBIO, is well-characterized for its activity against both Gram-positive and Gram-negative bacteria and is suitable for research applications requiring precision and reproducibility. Its defined pharmacokinetics and spectrum make it a valuable tool in studies of resistance mechanisms and gene transfer dynamics.